COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds

Schools have begun mass testing for COVID-19. But hurdles and uncertainties remain

Your Eyes May Reveal Your Alzheimer’s Disease Risk

Why did this year’s projected supply of COVID-19 vaccine for needy countries go down?